The global sales of non-invasive surgical wound closure is estimated to be worth USD 2,473.2 million in 2025 and anticipated to reach a value of USD 3,696.2 million by 2035. Sales are projected to rise at a CAGR of 4.1% over the forecast period between 2025 and 2035. The revenue generated by non-invasive surgical wound closure in 2024 was USD 2,375.8 million. The industry is anticipated to exhibit a Y-o-Y growth of 4.0% in 2024.
Non-invasive surgical wound closure is a technique that requires no stitches. These methods are designed to promote healing by securely closing the wound. This technique allows faster recovery with limited risk of infection. Common type of non-invasive surgical wound closures are adhesive strips, tissue adhesives, and staples.
Growing advancement in biomaterials, preference for less invasive procedures, reduced recovery times, and lesser scarring anticipates the growth of the market. Moreover, growing use of this techniques outpatient facilities owing to its easy to apply, economical, and painless nature contributing to the growth of the market.
Global Non-invasive Surgical Wound Closure Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 2,375.8 million |
| Estimated Size, 2025 | USD 2,473.2 million |
| Projected Size, 2035 | USD 3,696.2 million |
| Value-based CAGR (2025 to 2035) | 4.1% |
Non-invasive methods in surgical wound includes products such as adhesive strips, skin adhesives, surgical staples, and bioengineered dressings. They are an alternative to the conventional suture or stapler closure methods.
The increasing patient comfort, fast recovery times, and decreased healthcare expenditure have encouraged healthcare professionals to use non-invasive approaches.
Developments in the material of usage, bio-absorbable adhesives, and better technologies that aid wound healing significantly anticipate the growth of the market. Products such as surgical staples and Bioengineered dressings are gaining significant traction, owing to their advantages such as reduced healing time.
The forecast period anticipates substantial growth in the sales of non-invasive surgical wound closure devices, with an incremental opportunity of USD 1,320.5 million. Projections indicate that the market will expand to 1.6 times its current value by 2035.
Increasing demand for less invasive procedures, growing number of outpatient surgeries and minimally invasive techniques further propels the growth of the market.
Moreover, the growing emphasis of manufacturers on advancing wound management systems, along with integration of tissue regeneration products propels the growth for this products. Therefore, the advantages provided by non-invasive surgical wound closure such as less scarring, and minimized chances of infection, anticipate the growth of the market.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Comparative analysis of fluctuations in compound annual growth rate (CAGR) for the global non-invasive surgical wound closure sales between 2024 and 2025 on six months basis is shown below.
By this examination, major variations in the performance of these markets are brought to light, and also trends of revenue generation are captured hence offering stakeholders useful ideas on how to carry on with the market's growth path in any other given year. January through June covers the first part of the year called half1 (H1), while half2 (H2) represents July to December
The table presents the expected CAGR for the global non-invasive surgical wound closure sales over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2025 to 2035, the business is predicted to surge at a CAGR of 4.8%, followed by a slightly slower growth rate of 4.5% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 4.8% (2024 to 2034) |
| H2 | 4.5% (2024 to 2034) |
| H1 | 4.1% (2025 to 2035) |
| H2 | 3.6% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 4.1% in the first half and decrease moderately at 3.6% in the second half. In the first half (H1) the market witnessed a decrease of 70 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
Increase in adoption of Non-invasive Surgical Wound Closure in cosmetic and aesthetic surgeries Surges the growth of the market
Cosmetic procedures, such as facelifts, eyelid surgeries, and body contouring, requires minimally noticeable wound closures which has to be done precisely. Non-invasive adhesives in skin such as strips of adhesive tape are bioengineered in such a way that they leave fewer or no scars with faster healing process.
As patients demand quicker recovery, less visible scarring, and enhanced comfort after aesthetic treatments, non-invasive closures are an attractive alternative. They eliminate the process of painful stitch removals, lower the risk of infections, and minimize post-surgical discomfort, which makes them one of the preferred choice among cosmetic surgeons.
The demand for minimally invasive procedures and improving patient satisfaction with the process is also causing a trend in the non-invasive wound closure method in the aesthetic industry. This growing adoption of non-invasive surgical wound closure products in the cosmetic and aesthetic industry anticipate the growth of the market.
Strategic collaboration for expansion of their product reach anticipate the growth of the Market
Strategic partnerships are contributing a lot to the increase of the non-invasive surgical wound closure products reach and penetration. It has helped increase market growth as it helps companies get in touch with the target audience by collaborating with healthcare providers, surgical centers, and medical device companies.
These collaborations help firms tap into established distribution channels, reducing barriers to entry in various regions, particularly emerging markets where demand for advanced wound care solutions increases.
In addition, co-operation with research institutions and universities can foster innovation on non-invasive technologies resulting in the creation of more efficient, productized solutions specific to special needs in surgery. Together with this, such collaborative works allow companies to apply novel technologies like smart wound care or bioactive dressings onto their product lines and, thus, enable offering more holistic and cutting-edge solutions.
It also increases product presence in specialized fields such as aesthetic and cosmetic surgery through hospitals and cosmetic surgery clinics where the demand for the non-invasive wound-closing methods is on a rising trend. These strategic partnerships have the potential to hasten the adoption of non-invasive surgical wound closure products and increase market share to lead to growth.
For instance, in April 2020, BandGrip collaborated with Medline and signed a distribution partnership for expansion of their unique patented micro-anchor skin closure technology products.
Growing Advancement in Non-invasive skin closure device can bring new business growth opportunities to the Market players
Innovations in adhesive technologies, bioengineered dressings, and mechanical devices improve healing times, by reduced scarring, and enhanced patient comfort. Use of alternatives that are non-invasive as compared to sutures and staples which are associated with longer recovery periods and complications such as infections, healthcare providers are turning to these alternatives in greater numbers.
These factors have encouraged manufacturers to focus on introduction of new products such as zip tie skin closure. The market is witnessing significant adoption of this products owing to its faster and efficient closure of wounds, especially in areas under high tension, with minimum trauma to the surrounding tissues. The adjustable nature of the zip tie system allows for precision tension control, which reduces the risk of wound dehiscence and promotes optimal healing.
Quick application is advantageous in surgeries with high volumes and in emergency settings where time is a significant factor. Additionally, the low dependency on specific training make it attractive in inpatient and outpatient care.
With the emphasis on minimally invasive and rapid healing techniques among healthcare professionals, surgical zip tie closures are expected to significantly increase the adoption of non-invasive wound closure devices.
Competition from traditional wound closure techniques hinders the growth of the market
Non-invasive surgical wound closure faces significant competition in its adoption from traditional wound closure techniques as they are been trusted by healthcare professionals for generations. They have proven track record of effectiveness, reliability, and familiarity. Many surgeons become accustomed to the use of sutures and staples; thus, changing their methods to non-invasive ones requires a change in practice.
Another point is that conventional closure methods are usually more affordable, especially in less privileged environments. Non-invasive products, especially more sophisticated ones like bioactive dressings or smart wound care technologies, are typically costlier, thus not as attractive in price-sensitive markets. This price difference could affect the uptake of non-invasive solutions, especially in hospitals or clinics that do not have much to spare.
In addition, traditional methods have set clinical guidelines and training, whereas non-invasive products require further education and validation, thus delaying the general acceptance of the product. The strong usage of traditional methods coupled with the fear of effectiveness and cost of non-invasive alternatives slows the overall growth of the market.
The global sales of non-invasive surgical wound closure devices recorded a CAGR of 3.2% during the historical period between 2020 and 2024. The revenue growth was positive as it reached a value of USD 2,375.8 million in 2024 from USD 2,016.2 million in 2020.
Non-invasive surgical wound closure technique are generally used for the closure of surgical wounds without using any sutures, or staples. These technique has an inclusion of skin adhesive, bioengineered dressings, and surgical zip ties which work as an alternative to the traditional wound closure techniques.
The change in surgical practices towards more minimally invasive surgeries significantly contributes to the growth of the market. Its minimal size and precision nature, have attributed to its growing demand in the market. Increase in focus of manufacturers on the development of adhesive technologies and materials, including cyanoacrylate-based adhesives that provide secure and reliable closure without stitches anticipates the growth of the market.
This growing adoption by health professionals is due to faster recovery times, lower rates of complications such as infection, and more pleasing aesthetic outcomes for the patient. In these methods, scarring is much lower compared to other areas such as plastic and cosmetic surgery.
Bioactive and antimicrobial dressings are still on the current trends list, along with integration of smart wound care technologies. Non-invasive methods continue to increase in outpatient and emergency surgeries. The comfort it affords to the patient combined with its efficiency will help the market grow in the future as awareness, cost-effectiveness, and innovation are improved.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 64.6% in global market. These market leaders are characterized by high production capacity and a wide product portfolio.
These market leaders are distinguished by their extensive expertise in manufacturing and reconditioning across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base. Prominent companies within tier 1 include 3M Corporation, Baxter International Inc., Johnson and Johnson (Ethicon)
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 31.7% market share. These are characterized by a strong presence overseas and strong market knowledge.
These market players have good manufacturing technology and ensure regulatory compliance but may not have access to global reach. Prominent companies in tier 2 include Smith+Nephew, Medtronic, Aesculap AG & Co.KG
Finally, Tier 3 companies, act as a suppliers to the established market players. They specialize in specific products for catering to the niche markets.
Overall, Tier 1 companies are the primary drivers of the market, where Tier 2 and 3 companies make significant contributions, to the market ensuring the market remains dynamic and competitive.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section below covers the industry analysis for the non-invasive surgical wound closure market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America, with a value share of 58.7% through 2035. In Asia Pacific, China is projected to witness a CAGR of 5.8% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| UK | 3.4% |
| China | 5.8% |
| Japan | 4.2% |
| South Korea | 4.6% |
| Germany | 2.3% |
| India | 5.6% |
| Saudi Arabia | 3.8% |
USA market is poised to exhibit a substantial CAGR during the forecast period. Currently, it holds the highest share in the North American market, and the trend is expected to continue during the forecast period.
Minimally invasive procedures, such as robotic surgery, have grown in number, which has led to increase in demand for solutions that has ability to make wound closure with reduced incision. These are better suited with non-invasive methods of closure like skin adhesives and adhesive strips since they are known to provide rapid recovery time, minimal scarring, and a lower infection risk.
With the standardization of MIS among different surgical specialties, including general surgery and orthopedics, the demand for non-invasive wound closure products is expected to increase in the United States.
The applications bring benefits such as patient satisfaction and faster recovery times, making them increasingly used in healthcare, which is boosting the growth of this non-invasive wound closure systems market.
France currently holds around 36.4% share of the non-invasive surgical wound closure market. The market in France is anticipated to grow at a substantial CAGR throughout the forecast period.
The rising wave of adopting scarless surgeries in France is highly propelling the growth of the market. Scarless surgeries with minimal visible scarring as their goal and efficient result are increasingly adopted. For aesthetic and reconstructive treatments, non-invasive closure methods, such as adhesives for the skin, adhesive strips, and bioactive dressings, perfectly fit into the approach of scarless surgeries and support greater cosmetic outcomes and reduced time for recovery.
These products allow for smaller, cleaner incisions that heal faster and with less visible scarring, which is ideal for scarless surgery. The increasing demand for minimally invasive and aesthetic surgeries in France has seen health professionals look for non-invasive solutions to accommodate the preferences of patients on reduced scarring and faster healing.
This shift towards scarless procedures and non-invasive wound closures is anticipated to drive the market's growth, with benefits accruing to both patients and providers.
South Korea is expected to have a strong foothold when it comes to technology innovation. In 2024 the country is projected to account for substantial share of the non-invasive surgical wound closure market.
South Korea's increasing popularity for undergoing cosmetic and aesthetic surgeries enhances the growth in the use of non-invasive surgical wound closure products. Being one of the largest cosmopolitan centers of cosmetic procedure operations, with huge demands on facelift, eyelid, and body contouring operations, it offers a competitive advantage over others.
These patients seek minimal scarring and speedy recovery, making non-invasive methods of wound closure highly attractive, such as skin adhesives and bioactive dressings. Such methods reduce scarring, enhance faster healing, and decrease the risk of infection in comparison to traditional sutures and staples.
Furthermore, South Korea focuses on aesthetic outcomes, so non-invasive closures are preferred because they offer smoother, more aesthetically pleasing results. The growing demand for less invasive procedures and a greater emphasis on beauty and comfort are turning non-invasive wound closure products into the go-to solution in the country's cosmetic surgery sector, propelling market growth.
The section contains information about the leading segments in the industry. By product, adhesive segment is estimated to grow at a CAGR of 4.4% throughout 2035.
| Product | Adhesive |
|---|---|
| Value Share (2024) | 56.4% |
Adhesive segment dominate the non-invasive surgical wound closure market owing to several factors such as it produces minimal scarring, an attribute that makes the use of adhesives attractive in cosmetic and aesthetic surgery. They leaves behind relatively smaller and less conspicuous scars compared to sutures and staples.
In addition, it improves the patient comfort. The application and removal of adhesives are less painful compared to sutures, thus making overall patient experience better and the number of follow-up visits lower.
Furthermore, other factors such as it provides a good protective seal over the wound which reduces the chances of infection aid them in holding stronger position. Furthermore, advancements in adhesive technology, such as bioactive and synthetic adhesives, further anticipate their market growth. These factors contribute to making the adhesive segment one of the most robust in the market.
| End User | Hospitals |
|---|---|
| Value Share (2035) | 48.4% |
The hospitals segment is forecast to account for a share of 48.4% and is poised to expand at a CAGR of 3.4% across the forecast period.
The hospitals segment is a major shareholder in the market owing to several reasons such as they conduct a variety of surgical procedures, from general and orthopedic to cosmetic and aesthetic, hence they need versatile solutions for closing wounds. Hospitals carry out a very high number of operations daily, thus making an increased demand for these products.
Furthermore, the use of non-invasive closures supports better outcomes by having patients recover more promptly in minimal time within the hospital. In addition, advanced wound care technologies are also accessible to hospitals, so the non-invasive solutions have become more popular and are further strengthening their position in the market.
Substantial investments and focus is seen in this sector pertaining to non-invasive surgical wound closure which includes multiple product launches in this market. Another key strategic focus of these companies is to actively expand their geographical presence for strengthen their foothold in the market.
Recent Industry Developments in Non-invasive Surgical Wound Closure Market
In terms of Product, the industry is divided into adhesive, natural, synthetic, adhesive barrier products, hemostats, mechanical, active, flowable, sealants, fibrin and surgical
In terms of Application, the industry is segregated orthopedics, cosmetics, obstetrics and gynecology and others
The industry is classified by end user as hospitals, clinics, dermatological clinics, ambulatory surgical centers and emergency service centers
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa (MEA) have been covered in the report.
The global sales of non-invasive surgical wound closure devices is projected to witness CAGR of 4.1% between 2025 and 2035.
The global sales of non-invasive surgical wound closure devices stood at USD 2,375.8 million in 2024.
The overall revenue of non-invasive surgical wound closure devices is anticipated to reach USD 3,696.2 million by 2035 end.
China is set to record the highest CAGR of 5.8% in the assessment period.
The key players operating in this sector include Advanced Medical Solutions Group Plc, Ethicon Endo-Surgery, Inc, Abbott Laboratories, Baxter International Inc., Medtronic, Inc., CP Medical, Inc., Aesculap AG & Co.KG, Smith & Nephew, Surgical Specialties Corporation, Derma Sciences, Inc., Teleflex Medical OEM, Zipline Medical, Inc, Medi-zip GmbH, Takeda Pharmaceuticals International GmbH (Nycomed Pharma GmbH), BSN Medical, 3M Corporation and Pro-Motion Medical B.V.
| Market Size in 2023 | USD 275.1 million |
|---|---|
| Projected Market Size by 2033 | USD 371.5 million |
| Value-based CAGR (2023 to 2033) | 3.1% |
| Market CAGR (2023 to 2033) | 5.2% |
|---|---|
| Market Size (2023) | USD 4.54 billion |
| Market Size (2033) | USD 7.52 billion |
| Market CAGR (2022 to 2032) | 4.1% |
|---|---|
| Market Estimated Value (2022) | USD 383.3 Million |
| Market Projected Value (2032) | USD 593.6Million |
Explore Therapeutic Device Insights
View Reports
Non-invasive Surgical Wound Closure Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
